Justin J. McAnear - Nov 22, 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Financial Officer
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Justin J. McAnear
Stock symbol
TXG
Transactions as of
Nov 22, 2022
Transactions value $
-$55,392
Form type
4
Date filed
11/23/2022, 04:02 PM
Previous filing
Sep 16, 2022
Next filing
Feb 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$23.4K -686 -0.88% $34.07 77.7K Nov 22, 2022 Direct F1, F2
transaction TXG Class A Common Stock Sale -$22.2K -652 -0.84% $34.07 77.1K Nov 22, 2022 Direct F1
transaction TXG Class A Common Stock Sale -$9.81K -288 -0.37% $34.07 76.8K Nov 22, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 Includes 1 share acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 14, 2022.